Compare SNEX & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNEX | BAX |
|---|---|---|
| Founded | 1924 | 1931 |
| Country | United States | United States |
| Employees | 5400 | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 12.1B |
| IPO Year | 1996 | 1994 |
| Metric | SNEX | BAX |
|---|---|---|
| Price | $74.48 | $22.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 9 |
| Target Price | ★ $81.33 | $21.00 |
| AVG Volume (30 Days) | 987.8K | ★ 5.6M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.74 | N/A |
| Revenue | ★ $132,378,200,000.00 | $11,244,000,000.00 |
| Revenue This Year | N/A | $1.96 |
| Revenue Next Year | $4.17 | $2.22 |
| P/E Ratio | $20.02 | ★ N/A |
| Revenue Growth | ★ 32.53 | 5.72 |
| 52 Week Low | $68.00 | $15.73 |
| 52 Week High | $141.99 | $29.35 |
| Indicator | SNEX | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 24.57 | 57.08 |
| Support Level | $68.97 | $18.14 |
| Resistance Level | $105.18 | $23.61 |
| Average True Range (ATR) | 4.35 | 0.71 |
| MACD | -5.07 | -0.15 |
| Stochastic Oscillator | 10.57 | 54.12 |
StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.